EMA has approved Secukinumab for the expanded approvals for use in pediatric patients with enthesitis-related arthritis
Tweet Content
EMA has approved Secukinumab for the expanded approvals for use in pediatric patients with enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) . Approvals based on the JUNIPERA trial, showing reduced the risk of flare & Dz activity w/ SEC https://t.co/6pWc6nEUd9 https://t.co/gGGyzEEh0u
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off